Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Sierra Neuropharmaceuticals receives financing to advance epilepsy drug
September 2008
SHARING OPTIONS:

AURORA, Colo.Sierra Neuropharmaceuticals Inc., a formulator of pharmaceuticals for direct-to-the-brain treatment of neurological diseases, announced last month it completed a $21.5 million venture capital Series A financing co-led by HealthCare Ventures, Morgenthaler Ventures and Sequel Venture Partners. Sierra, which uses standard implantable pumps placed surgically under the skin to deliver drugs directly to the fluid around the brain via a catheter, will use the financing to develop a reformulated oral anti-convulsant to treat patients with refractory epilepsy. Sierra will announce the development of a second product in three to six months. Other Sierra investors included High Country Venture and GC&H Investments LLC. DDN

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.